Gene Editing | Precision Medicine in Practice - World Medical Innovation Forum

Gene therapy and gene editing are transforming how rare and widespread diseases are diagnosed, treated, and prevented. Advances in molecular precision enable tailored interventions at the individual level while supporting scalable solutions for larger populations. This panel will explore how novel gene therapy and editing tools are revolutionizing the diagnosis, treatment and prevention of diseases at an individual and population-based level. Experts will discuss the latest breakthroughs in gene editing and the challenges that come with translating these innovations into widespread and effective clinical care.

Moderator

Benjamin Kleinstiver, PhD,

Investigator, Center for Genomic Medicine; Kayden-Lambert MGH Research Scholar 2023-2028, Mass General Brigham;

Associate Professor of Pathology, Harvard Medical School

Speakers

Omar Abudayyeh, PhD,

Director of Gene Editing, Gene and Cell Therapy Institute, Mass General Brigham;

Assistant Professor of Medicine, Harvard Medical School

Steve Favaloro

Chairman & CEO, Genezen

David Liu, PhD

Richard Merkin Professor; Director, Merkin Institute of Transformative Technologies in Healthcare, Broad Institute

Laura Sepp-Lorenzino, PhD

Executive Vice President, Chief Scientific Officer, Intellia Therapeutics